| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1086957 | Le Pharmacien Hospitalier et Clinicien | 2015 | 11 Pages |
Abstract
The primary aim of this review is to provide an up-to-date evaluation of the clinical evidence for using linezolid to treat MRSA nosocomial pneumonia, with a focus on recently published studies. The second objective is to evaluate the cost-effectiveness of linezolid compared to other agents.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
G.G. PharmD, S. PharmD, PhD, J. PharmD, PhD, D. MD, PhD, D. PharmD, PhD,